Cordis Webster
This article was originally published in The Gray Sheet
Executive Summary
Additional indications for the Celsius 6 and 7 Fr. temperature ablation catheters are approved Jan. 26 via premarket approval application supplement. The Johnson & Johnson unit's deflectable tip catheters are the first to gain U.S. clearance for the pediatric market and can be used on patients age four and older. Other indications include the interruption of accessory atrioventricular (AV) pathways associated with persistent junctional reciprocating tachycardia (PJRT), and treatment of Mahaim fibers, a congenital anomaly that creates accessory conduction pathways